ESSA Pharma Inc. 4/A SEC Filings

Filed On	Filing
26 Jan 2021	Form 4/A: Zweifach Sanford S, Director Granted 16,500 Stock Option (Right to Buy)
26 Jan 2021	Form 4/A: Thorell Marella, Director Granted 16,500 Stock Option (Right to Buy)
26 Jan 2021	Form 4/A: Sollis Gary, Director Granted 16,500 Stock Option (Right to Buy)
26 Jan 2021	Form 4/A: Requadt Scott, Director Granted 16,500 Stock Option (Right to Buy)
26 Jan 2021	Form 4/A: Martin John Alexander, Director Granted 16,500 Stock Option (Right to Buy)
26 Jan 2021	Form 4/A: Glickman Richard M, Director Granted 25,000 Stock Option (Right to Buy)
26 Jan 2021	Form 4/A: Brettman Ari David, Director Granted 16,500 Stock Option (Right to Buy)
26 Jan 2021	Form 4/A: Berger Franklin M, Director Granted 16,500 Stock Option (Right to Buy)

Comments